We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 9,634

Trump Administration Issues Memorandum on DACADAPA
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • June 16 2017

On June 15th, the Department of Homeland Security (DHS) issued a brief memorandum on the status of DAPA. DAPA (Deferred Action for Parents of


Physician, Regulate Thyself: Antitrust Class Action Alleging Physician Association Tied Board Certification to Association Membership Survives Motion to Dismiss
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • June 16 2017

A New Jersey district court recently denied a motion to dismiss in an antitrust class action alleging that a physician association illegally tied


The Rise of the Group Health Insurance Captive
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • June 15 2017

With its “employer mandate”i.e., the requirement that applicable large employers make an offer of group health coverage to substantially all


OCR Publishes Checklist and Infographic for Cyber Attack Response
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • June 14 2017

OCR released a simple checklist and infographic last week to assist Covered Entities and Business Associates with responding to potential cyber


Amgen v. Sandoz: The Supreme Court’s First Biosimilars Ruling
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • June 14 2017

In a unanimous decision issued on June 12, 2017, the Supreme Court for the first time interpreted key provisions of the 2010 Biologics Price


“Class Arbitration”: The Current Law
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • June 14 2017

We recently began a series of articles in which we ask whether “class arbitration” meaning the utilization of a Federal Rule of Civil Procedure 23


PTAB Invalidates Two Cisco Patents Found Valid and Infringed at the ITC
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • June 14 2017

The Patent Trial and Appeal Board (“PTAB”) issued Final Written Decisions regarding Cisco’s U.S. Patent Nos. 6,377,577 (the “’577 Patent”) and 7,023


SCOTUS Ruling Gives a Boost to Biosimilars; FDA Continues to Advance Products Through AdComs
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • June 14 2017

On a sweltering hot D.C. morning, those of us anxiously awaiting the Supreme Court’s opinion in its first case involving biosimilar biological


Pumping Up Exceptional Cases Under the Octane Fitness Standard
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • June 13 2017

A flurry of activity from various courts this past week on “exceptional cases” under Section 285 of the Patent Act provided notable guidance for


Seventh Circuit OKs Exclusive Network Agreements Between “Must-Have” Hospital and Health Insurers
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • June 12 2017

In an opinion written by Judge Posner, the Seventh Circuit on Friday gave its stamp of approval to a “must-have” hospital’s bargaining to exclude